11-β-hydroxylase inhibitorを用いた小児の間脳-下垂体-副腎皮質系ホルモン分泌機構に関する研究:第二編 間脳-下垂体-副腎皮質系の発達に関する検討と血中metyrapone. reduced metyrapone濃度に基づくmetyrapone試験の検討-特に, glucocorticoid系とmineralocorticoid系との比較を中心として-
スポンサーリンク
概要
- 論文の詳細を見る
This study was designed to investigate the development of the hypothalamo-pituitaryadrenocortical function in children. <BR>In order to study age-differences, normal subjects were divided into three groups by age (A : 10 y/o -15 y/o, B : 5 y/o -9 y/o and C : 6 m/o -3 y/o).<BR>The time course levels of plasma ACTH, serum 11-deoxycortisol, 11-deoxycorticosterone, cortisol, corticosterone, metyrapone and reduced metyrapone after a single oral or rectal administration of metyrapone were measured simultaneously by radioimmunoassay and gas chromatograph-mass spectrometry. These data were statistically analyzed.<BR>The degree of inhibition of 11-β-hydroxylase activity was expressed by usings S/SF+ × 10<SUP>2</SUP> and DOC/DOC+B × 10<SUP>2</SUP> as the inhibitory indices in the glucocorticoid pathway and mineralocorticoid pathway.<BR>After the administration of metyrapone, both maximum levels of plasma ACTH and the area under the curve (AUC) of plasma ACTH were higher and greater in the A group than in the other younger groups (by AIC). The response of serum 11-doxycortisol to the increase in plasma ACTH was greater according to age groups A>B>C (by AIC). In marked contrast, the response of serum deoxycorticosterone to the increase in plasma ACTH was greater according to age groups C>B>A (by AIC).<BR>These findings suggest that the hypothalamo-pituitary-adrenocortical function differs with age and also that the development of the glucocorticoid pathway differs from that of the mineralocorticoid pathway in children.<BR>The ratio of the increase of the S/S+F × 10<SUP>2</SUP> value to the increase of serum tota metyrapone (metyrapone plus reduced metyrapone) levels was greater according to age DOC groups A>B>C (P<0.05). In contrast, the ratio of increase of the DOC/DOC+B × 10<SUP>2</SUP> value to the increase of serum total metyrapone levels showed completely opposite results (C>B>A : P<0.05).<BR>The discrepancies in these inhibitory patterns of 11-β-hydroxylase activity suggest the maturation with age and the heterogenity of the 11-β-hydroxylase between the glucocorticoid and mineralocorticoid pathways.<BR>After discontinuation of more than 1 month of long-term prednisolone therapy, the response of serum 11-deoxycortisol to the metyrapone test did not completely return to normal responses in the control subjects.<BR>This finding indicates that the recovery of the hypothalamo-pituitary-adrenocortical function may require more than 1 month under such conditions.<BR>In patients with ACTH deficiency, plasma ACTH did not respond to the administration of metyrapone; however, serum 11-deoxycortisol and deoxycorticosterone levels showed a significant increase over the normal serum circadian range of 11-deoxycortisol and deoxycorticosterone (P<0.01).<BR>These findings suggest not only a minute amount of pituitary ACTH secretion but also the autonomous function of the adrenal gland.<BR>Furthermore, in ACTH deficient patients, the inhibitory patterns of S/S+F × 10<SUP>2</SUP> and DOC/DOC+B × 10<SUP>2</SUP> to the increase of serum total metyrapone were indicated to be the same as in normal children.<BR>When we analyzed those cases showing a false negative response on the metyrapone test (i.e. cases whose maximum plasma ACTH increase was below 154 pg/ml : M + 3SD circadian ranges of plasma ACTH levels in the controls), the serum total metyrapone levels were found to be below 1.7 μg/ml in all; thus serum maximum levels of total metyrapone in a single metyrapone test must be checked so as to be above 1.7 μg/ml in order to evaluate normal pituitary function.<BR>In the clinical application of a single metyrapone test (50 mg/kg, rectal administration), the demarcation points between the normal control group and the groups with abnormal ACTH secretion were 6.9 μg/di for 11-deoxycortisol and 7.2 ng/ml for deoxycorticosterone.<BR>To summarize;
- 一般社団法人 日本内分泌学会の論文